- Home
- Equipment
- north america
- coronary bypass
Refine by
Coronary Bypass Equipment Supplied In North America
13 equipment items found
Manufactured by:Voss Medical Products based inSan Antonio, TEXAS (USA)
The VM/CV By-Pass Clamp combines compact size, supple pads and soft spring-action closing force to provide an appropriate amount of pressure during grafting. Sterile, ...
Manufactured by:Voss Medical Products based inSan Antonio, TEXAS (USA)
The unique design of the VM/CV Disposable Coronary Bypass Vein Cannula combines a stainless steel 18G needle stock barrel with a standard plastic friction-fit/twist-on hub and a special plastic tip for a atraumatic ...
Manufactured by:Voss Medical Products based inSan Antonio, TEXAS (USA)
HE VM/CV Coronary By-Pass Marker: Easier to use. Easier to locate and remove. The VM/CV Coronary By-Pass Graft Marker provides a blue, radiopaque marker that is easier to locate, cut, bend and remove and is suitable for patients requiring ...
Manufactured by:Vascudyne, Inc. based inStillwater, MINNESOTA (USA)
Hyperplasia, calcification, foreign body immune response, infection, and atheroma formation are commonly encountered limiting the use of synthetic grafts, with none available for small diameter applications like coronary ...
Manufactured by:LeMaitre Vascular, Inc. based inBurlington, MASSACHUSETTS (USA)
The 1.5 mm diameter and hydrophilic coating allow for easier insertion and enhanced trackability through the vein in a more atraumatic fashion. The blade range of 1.5 mm - 6.0 mm diameter provides valve cutting in smaller diameter veins while retaining its ability to cut valves in larger diameter vessels. This innovative device uses unique self-sizing, self-centering hoops for well positioned, ...
Manufactured by:XyloCor Therapeutics based inWayne, PENNSYLVANIA (USA)
XC001 is an investigational gene therapy for the treatment of patients with refractory angina with no treatment options. Patients who have exhausted pharmacologic options and are not eligible for PCI or coronary artery bypass grafts become sedentary because of their symptoms and this can exacerbate comorbidities causing rapid deterioration of their health status ...
Manufactured by:Healionics based inSeattle, WASHINGTON (USA)
The graft will initially address the urgent need for improved vascular access for hemodialysis patients, with subsequent applications to peripheral artery disease, vascular trauma, and potentially coronary artery bypass. We are also developing a device to enable needle-free hemodialysis ...
Manufactured by:AtriCure, Inc. based inMason, OHIO (USA)
The Isolator Synergy ablation clamp is the FIRST and ONLY surgical ablation device offered with FDA approval for the treatment of Atrial Fibrillation (Afib) and the only device either Catheter or Surgical to be approved for the treatment of persistent and long-standing persistent ...
Manufactured by:Revotek Co., Ltd. based inLewes, DELAWARE (USA)
It is estimated by the World Health Organization that the current global prevalence of advanced vascular disease is ~175mm people and increasing. One of the most common clinical interventions to treat advanced vascular disease is the replacement of stenotic or occluded arteries with vascular grafts. This is often accomplished utilizing autologous veins/arteries or through synthetic conduits ...
Manufactured by:XyloCor Therapeutics based inWayne, PENNSYLVANIA (USA)
Coronary Artery Bypass Graft Surgery or CABG is a procedure used to treat coronary artery disease – the narrowing or blockage of the blood vessels that supply oxygen and nutrients to the heart muscle. During CABG, a healthy artery or vein from the body is connected, or grafted, to the blocked coronary artery. The grafted ...
by:Marizyme, Inc. based inJupiter, FLORIDA (USA)
DuraGraft®- Marizyme’ s flagship product is a first-in-class product used during Coronary Artery Bypass Grafting (CABG surgery) to help prevent vein graft failure and its complications. DuraGraft® is a biocompatible intraoperative vascular graft storage and flushing solution that maintains the graft’s endothelial function and structure by ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Aprotinin is a bovine pancreatic trypsin inhibitor (BPTI) inhibitor which inhibits trypsin and chymotrypsin with Kis of 0.06 pM and 9 nM, ...
Manufactured by:Palisade Bio based inCarlsbad, CALIFORNIA (USA)
Our lead asset LB1148 is a novel oral liquid formulation of the well-characterized digestive enzyme inhibitor, tranexamic acid (“TXA”), with potential to both reduce abdominal adhesions and help restore bowel function following surgery. The therapy is being developed for administration prior to major surgeries that are at risk of disrupting the intestinal epithelial ...